Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1107

1.
2.

Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.

Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, Smith WC, Jung RT, Campbell MK, Grant AM.

Health Technol Assess. 2004 May;8(21):iii-iv, 1-182. Review.

3.

What are the long-term benefits of weight reducing diets in adults? A systematic review of randomized controlled trials.

Avenell A, Brown TJ, McGee MA, Campbell MK, Grant AM, Broom J, Jung RT, Smith WC.

J Hum Nutr Diet. 2004 Aug;17(4):317-35. Review.

PMID:
15250842
4.

Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up.

Franz MJ, VanWormer JJ, Crain AL, Boucher JL, Histon T, Caplan W, Bowman JD, Pronk NP.

J Am Diet Assoc. 2007 Oct;107(10):1755-67. Review.

PMID:
17904936
6.

X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.

Toplak H, Ziegler O, Keller U, Hamann A, Godin C, Wittert G, Zanella MT, Zúñiga-Guajardo S, Van Gaal L.

Diabetes Obes Metab. 2005 Nov;7(6):699-708.

PMID:
16219013
7.

Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.

Derosa G, Cicero AF, Murdolo G, Ciccarelli L, Fogari R.

Diabetes Nutr Metab. 2004 Aug;17(4):222-9.

PMID:
15575343
8.
9.

Efficacy and safety of anti-obesity drugs in children and adolescents: systematic review and meta-analysis.

Viner RM, Hsia Y, Tomsic T, Wong IC.

Obes Rev. 2010 Aug;11(8):593-602. doi: 10.1111/j.1467-789X.2009.00651.x. Epub 2009 Nov 17. Review.

PMID:
19922432
10.

Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis.

Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, Kim C, Lau J.

Arch Intern Med. 2004 Jul 12;164(13):1395-404. Review.

PMID:
15249348
11.

Comparison of orlistat and sibutramine in an obesity management program: efficacy, compliance, and weight regain after noncompliance.

Gursoy A, Erdogan MF, Cin MO, Cesur M, Baskal N.

Eat Weight Disord. 2006 Dec;11(4):e127-32.

PMID:
17272944
12.

The efficacy and safety of sibutramine for weight loss: a systematic review.

Arterburn DE, Crane PK, Veenstra DL.

Arch Intern Med. 2004 May 10;164(9):994-1003. Review.

PMID:
15136309
13.

Systematic review of randomized controlled trials of low-carbohydrate vs. low-fat/low-calorie diets in the management of obesity and its comorbidities.

Hession M, Rolland C, Kulkarni U, Wise A, Broom J.

Obes Rev. 2009 Jan;10(1):36-50. doi: 10.1111/j.1467-789X.2008.00518.x. Epub 2008 Aug 11. Review.

PMID:
18700873
14.

Prediction of response to sibutramine therapy in obese non-diabetic and diabetic patients.

Finer N, Ryan DH, Renz CL, Hewkin AC.

Diabetes Obes Metab. 2006 Mar;8(2):206-13.

PMID:
16448525
15.
16.

Comparison of efficacy of sibutramine or orlistat versus their combination in obese women.

Sari R, Balci MK, Cakir M, Altunbas H, Karayalcin U.

Endocr Res. 2004 May;30(2):159-67.

PMID:
15473126
17.

Weight management and current options in pharmacotherapy: orlistat and sibutramine.

Leung WY, Thomas GN, Chan JC, Tomlinson B.

Clin Ther. 2003 Jan;25(1):58-80. Review.

PMID:
12637112
18.

Meta-analysis: pharmacologic treatment of obesity.

Li Z, Maglione M, Tu W, Mojica W, Arterburn D, Shugarman LR, Hilton L, Suttorp M, Solomon V, Shekelle PG, Morton SC.

Ann Intern Med. 2005 Apr 5;142(7):532-46.

PMID:
15809465
19.

Orlistat and sibutramine beyond weight loss.

Mannucci E, Dicembrini I, Rotella F, Rotella CM.

Nutr Metab Cardiovasc Dis. 2008 Jun;18(5):342-8. Epub 2007 Oct 24.

PMID:
17928208
20.

Comparison of the effects of sibutramine and orlistat on obese, poorly-controlled type 2 diabetic patients.

Chou KM, Huang BY, Fanchiang JK, Chen CH.

Chang Gung Med J. 2007 Nov-Dec;30(6):538-46.

Supplemental Content

Support Center